您所在的位置:河大科研处 >>  学术活动专栏  >> 正文  
施进军:Bioresponsive RNA Nanomedicines(时间8.7)
【 作者:  校对时间:2019年08月07日 09:51  访问次数: 】

报告人:施进军  哈佛大学医学院副教授

报告时间:8月7日16:00-17:00

报告地点:药学院2楼会议室

主办单位:药学院

欢迎光临!

    Dr. Shi is an Associate Professor at Harvard Medical School, and a faculty member in the Center for Nanomedicine and Department of Anesthesiology at Brigham and Women’s Hospital. His lab is interested in basic and applied science in the field of nanomedicine. His research involves a highly interdisciplinary combination of nanotechnology, biomaterials, drug delivery, immunotherapy, and antioxidative therapy for biomedical applications in cancer, atherosclerosis, and other diseases. He has developed various nanoparticle platforms for effective delivery of therapeutics ranging from small molecules to RNAs and proteins. Notably, the immunonanotherapeutics developed by him and colleagues using self-assembled polymeric nanoparticles has resulted in the clinical trials of synthetic nanoparticle vaccines for different diseases. His current research focuses include: i) RNAi nanotechnology for gene silencing; ii) mRNA delivery for restoration of tumor suppressors; and iii) development of stimuli-responsive nanomaterials and bioinspired antioxidative polymers. He has also received the K99/R00 Career Development Award from National Institutes of Health, the Young Investigator Award and the Movember Challenge Award from Prostate Cancer Foundation, the Lung Cancer Discovery Award from American Lung Association, and other awards.